Dietary Supplement Regulation Update: FDA Announces Public Meeting on Responsible Dietary Supplement Innovation; FDA Launches Dietary Supplement Ingredient Advisory List

As a part of the Food and Drug Administration’s (FDA’s) initiative to modernize and reform dietary supplement oversight, FDA announced it will hold a public meeting on responsible innovation in dietary supplement manufacturing on May 16, 2019. FDA also recently unveiled a new Dietary Supplement Ingredient Advisory List, a rapid-response tool intended to quickly alert the public when FDA identifies ingredients that do not appear to be lawfully marketed dietary supplements. FDA has listed four ingredients on the list so far: andarine, higenamine, hordenine, and 1,4-DMAA. This memorandum summarizes these developments. 

Click here to read the full article.

Download PDF Back To Listing